Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 500 participants.

Also called NCT07279909

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 500 participants (enrolled count) (from the registry)
Sponsor
Hamdard University (from the registry)
Registry
  • NCT NCT07279909
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07279909. Non-randomized; no masking; primary purpose treatment. Start 2024-03-09 (actual); primary completion 2025-08-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation
Condition
Diabetes Type 2
Condition
Diabetes Mellitus, Experimental
Condition
HbA1c (A1C)
Condition
Urinary Glucose
Condition
Ability of Experimental Drug to Lower HbA1c Compare to Metformin
Intervention (Drug)
DIAB-PHC1
Intervention (Drug)
Metformin
Lead sponsor
Hamdard University (class: other)
Collaborator
Jinnah Postgraduate Medical Centre (class: other government)

Record details

Record id
cardio:ct-nct07279909
Content hash
972256e2a2a99a8565dd0ec9b87aded91ab9a6c873413f9df2ac3164ccc85ae3